Donald Lazas
Hermitage, TNNPI 1427055326
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,100 of the $3,148 with a category attached, or 66.7%. Novo Nordisk accounts for 66.7% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $2,203 and has fallen 98.6% since, to $31 in 2024.
Across 43 payments — averaging $73.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- Novartis$358
- AbbVie$173
- Bristol Myers Squibb$113
- Johnson & Johnson$103
- Ferring Pharmaceuticals Inc.$64
- plus $238 from 9 others
Across 244 payments — averaging $4344.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$577K
- Novartis$410K
- Alnylam Pharmaceuticals Inc.$41K
- Novo Nordisk AS$32K
What the payments were for
- Consulting fees$2,10067%
- Travel & lodging$2267%
- Food & beverage$78825%
- Other$341%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 2 | $2,100 |
| Novartis | 2 | $358 |
| AbbVie | 10 | $173 |
| Bristol Myers Squibb | 6 | $113 |
| Johnson & Johnson | 7 | $103 |
| Ferring Pharmaceuticals Inc. | 3 | $64 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $50 |
| Ironwood Pharmaceuticals, Inc | 3 | $47 |
| Baxter Healthcare | 1 | $34 |
| Organon | 1 | $23 |
| Medtronic | 1 | $20 |
| Fresenius Kabi USA, LLC | 1 | $18 |
| QOL Medical, LLC | 1 | $17 |
| Pfizer | 1 | $16 |
| Intercept Pharmaceuticals, Inc. | 1 | $14 |
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 11 | $294 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.